> But what’s the rush, asks Peter Doshi, and is just six months of data from now unblinded trials acceptable?<p>> Unblinded and without a control group—what about safety?<p>There shouldn't be a rush. Now that such a large number of people who wanted it has gotten it, we might as well do the full 10-years-plus process of seeing all the effects and going through the normal process. It shouldn't be used as a reason to say "no more studies needed, since it got approval", or "emergency authorisation seems to have worked, so let's just skip to full approval".